Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The primary purpose of this study is to evaluate the safety and tolerability of a single intradermal administration of RXI-109 at small surgical incisions in the abdominal skin that will later be removed during an elective abdominoplasty. The effect of RXI-109 versus placebo on scarring at these incision sites will be evaluated visually and histologically.
Epistemonikos ID: 780dba310fa568507467b8f3c2f344d0cf2f54d0
First added on: May 11, 2024